In summary, using murine and single-cell TEMs, we reveal that the glucose-competition/NSUN2 axis drives metabolic reprogramming in malignant cells through an m5C modification-dependent manner, serving as a key driver of HCC evolution. This evidence concerns the gene NSUN2 and hepatocellular carcinoma.